Detalhe da pesquisa
1.
Efficacy and safety of the contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive in Chinese women: a 1-year randomised trial.
Eur J Contracept Reprod Health Care
; 21(4): 303-9, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27339759
2.
Safety and efficacy of the NuvaRing® Applicator in healthy females: a multicenter, open-label, randomized, 2-period crossover study.
Contraception
; 94(4): 362-5, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27207028
3.
Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised, placebo-controlled study.
Curr Med Res Opin
; 19(5): 383-94, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-13678475
4.
Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled, exploratory study.
Clin Ther
; 31(8): 1747-53, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19808133